The FDA Orange Book, or Approved Drug Products with Therapeutic Equivalence Evaluations, is the definitive source to link drugs with the patents that protect them.
Over the years we’ve had many requests from academic groups and commercial clients alike for historical archives of the Orange Book. In response, DrugPatentWatch has issued Freedom-of-Information requests to the Food and Drug Administration and has also obtained copies of the Orange Book from libraries around the world. The team at DrugPatentWatch is proud to make this resource freely available.
For more information on how to use the Orange Book, see 3 Uses for the FDA Orange Book
Table of Contents
Going Beyond the Orange Book
The DrugPatentWatch database builds on the Orange Book by incorporating deep data on US and Global Patents, and broad details such as abandoned and pending patent applications, drug formulation, manufacturers and suppliers, tentative approvals, clinical trials and more. For more details see the DrugPatentWatch homepage and flexible subscription options
Check out our comprehensive downloadable Orange Book PDF library at https://www.drugpatentwatch.com/p/fda-orange-book/
